The New York Entrepreneur

Bayer’s stock surges after U.S. appeals court strikes down Roundup cancer case

Read Time:9 Second

A U.S. appeals court ruled Bayer should be shielded from claims that subsidiary Monsanto failed to adequately warn users about cancer risks linked to the popular weed killer Roundup.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post I own stocks with my wife. Should we wait until one of us dies to sell them?
Next post Arbitrum DAO okays proposal to boost ARB performance and treasury security